The Importance of Early Diagnosis in EoE

In ‘The Importance of Early Diagnosis in EoE,’ our panel explores why recognizing eosinophilic esophagitis as a chronic, progressive disease reinforces the need for timely diagnosis and disease control. The expert faculty discuss how persistent, untreated inflammation can contribute to esophageal remodeling, fibrosis, and stricture formation over time, emphasizing that the goals of care extend beyond addressing a patient’s immediate symptoms.

The panelists examine how diagnostic delays may increase the risk of fibrostenotic disease and explain why this is particularly important when counseling younger patients who may have decades of disease ahead of them. They discuss the challenge of communicating long-term risks to patients who may be minimally symptomatic or feel better after an acute event, such as a food impaction that resolves spontaneously. Rather than focusing exclusively on short-term symptom relief, the panel emphasizes the importance of identifying and treating underlying inflammation to help prevent disease progression.

The expert faculty also share practical approaches for helping patients understand the chronic nature of EoE and the value of pursuing diagnostic evaluation. Visual models of the esophagus and relatable analogies can help patients conceptualize inflammation and structural changes that they cannot see or may not yet feel. Throughout the discussion, the panel underscores the importance of patient education and shared understanding in encouraging appropriate evaluation and long-term engagement in care. Ultimately, earlier diagnosis provides an opportunity to address inflammation before progressive structural changes create a greater clinical burden for patients.

Our next episode, ‘Addressing Diagnostic Delays in EoE,’ examines how APPs can help overcome barriers to earlier EoE recognition through comprehensive histories, collaboration, and clinician education. The panelists also discuss how delayed diagnosis and inadequate disease control can contribute to fibrostenotic progression and greater long-term disease burden.